Vertex advances APOL1 kidney disease therapy to Phase III portion of trial
Vertex Pharmaceuticals has confirmed the progression of inaxaplin (VX-147) into the Phase III portion of the international Phase II/III pivotal…
Vertex Pharmaceuticals has confirmed the progression of inaxaplin (VX-147) into the Phase III portion of the international Phase II/III pivotal…
Eli Lilly has reportedly commenced Phase III clinical trials of oral medication, orforglipron, for weight loss in India. The oral…
Benchling, a US-based life sciences software company, has confirmed that it has laid off around 9% of its workforce. The…